GET THE APP

Evaluation of pathogenesis and sensitivity pattern of the microorganisms involved in the urinary tract infection against common antibiotics in inpatients and outpatients of Imam Khomeini hospital of Ardabil in 2016 | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Evaluation of pathogenesis and sensitivity pattern of the microorganisms involved in the urinary tract infection against common antibiotics in inpatients and outpatients of Imam Khomeini hospital of Ardabil in 2016

Author(s): Hosein Behzad, Mahdi Rahbar, Bohlool Habibi asl , Milad Ghanizadeh

Background: Urinary tract infection (UTI) is the most common human bacterial infection that affects different age groups and can occur anywhere in the urinary tract. In this article, we tried to assess the pathogenic and antibiotic susceptibility pattern of these pathogens in inpatients and outpatients of Imam Khomeini hospital of Ardabil. Materials and Methods: In this retrospective and descriptive cross-sectional study we evaluated list of all patients using hospital information system (HIS) software and the result of urinary culture and gender and type of admission were recorded. Obtained data from the study were studied using descriptive statistics. Results: In outpatients and inpatients E. coli was agent in 74 cases (59.6%) and 72 cases (53.7%) respectively. The highest levels of antibiotic sensitivity of E. coli in outpatient and inpatients were to drugs of nitrofurantoin (72.9-70.8) and amikacin (56.7-48.6). The highest rates of antibiotic resistance of E. coli in outpatients were to drugs of cotrimoxazole (35.1 percent), ampicillin (24.3 percent) and ciprofloxacin (24.1 percent) and in hospitalized patients were to drugs of ciprofloxacin (40.2 %), ampicillin (37.5 percent) and gentamicin (27.7 percent). Conclusion: E. coli is the main cause of urinary tract infection in inpatients and outpatients of Imam Khomeini hospital of Ardebil and the most effective antibiotics are nitrofurantoin and amikacin in empirical treatment for these patients.